NOVARTIS AG (NVSEF)
Clinical trial NCT06955169 updates: 1. enrollment: 4 → 130 participants 2. enrollment type: ACTUAL → ESTIMATED
Clinical trial NCT06955169 updates: 1. enrollment: 4 → 130 participants 2. enrollment type: ACTUAL → ESTIMATED
Clinical trial NCT07631286: start date: 2026-06-01 → 2026-06-15.
Clinical trial NCT04572451 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-31 → 2027-08-05 3. primary completion date: 2024-05-17 → 2026-10-07
Clinical trial NCT06185764 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 52 → 47 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03661307: status: SUSPENDED → RECRUITING.
Clinical trial NCT06494540 updates: 1. completion date: 2028-06-30 → 2029-12-31 2. primary completion date: 2028-06-30 → 2029-12-31
Clinical trial NCT07283705: start date: 2026-05-18 → 2026-04-09.
Clinical trial NCT07123090 updates: 1. completion date: 2028-02-01 → 2028-04-01 2. primary completion date: 2026-10-01 → 2027-10-01
Clinical trial NCT07712874: start date: 2026-08-24 → 2026-08-25.
Clinical trial NCT06505005 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. completion date: 2026-05-01 → 2026-08-01 3. primary completion date: 2026-05-01 → 2026-08-01 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04933903 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-10-01
Clinical trial NCT06794996 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-30 → 2026-07-20 3. primary completion date: 2026-12-30 → 2026-07-20
Clinical trial NCT07630974: start date: 2026-07-02 → 2026-07-06.
Clinical trial NCT07673081 updates: 1. status: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-06-20 → 2026-06-22 3. completion date: 2026-11-30 → 2026-09-30 4. primary completion date: 2026-11-30 → 2026-09-30
Clinical trial NCT05915728: enrollment: 404 → 410 participants.